At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Vigiis 101-LAB +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Functional Assessment in The Intestinal Flora Improvement
In Brief
A clinical study evaluating Vigiis 101-LAB and Placebo for Gastrointestinal Microbiome. Completed, enrolled 36 participants across 1 site.
Detailed Summary
This clinical trial was conducted as part of the "Methods for Evaluating the Improvement of Gastrointestinal Function in Health Food" announced by the Department of Health, DOH (currently known as Ministry of Health and Welfare, MOHW) on the test article, "Vigiis 101-LAB powder (Capsules)", manufactured by SunWay Biotech Co., Ltd.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Microbiome
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
Primary CompletionJul 2016
Study CompletionDec 2016
First PostedSep 2019
TodayJul 2026
First PostedSep 12, 2019
Enrollment StartMar 5, 2016
Primary CompletionJul 6, 2016
Study CompletionDec 18, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.8 years ago
Interventions
Vigiis 101-LABdietary
examined the effects of the Vigiis 101-LAB capsules (5 billion CFU/day)
Placebodietary
Maltodextrin was used as a placebo